Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Mid Day Review

Market behaviours during the course of the trading session.

 
Equity benchmarks trade below flat line; pharma shares edge higher
27-Sep-23 12:22Hrs IST

The domestic equity benchmarks traded below the flat line, with minor cuts, in afternoon trade. The Nifty traded tad above the 19,650 mark. Pharma shares advanced as value buying emerged at lower levels.

At 12:20 IST, the barometer index, the S&P BSE Sensex, was down 28.56 points or 0.04% to 65,916.91. The Nifty 50 index lost 1.90 points or 0.01% to 19,662.80.

In the broader market, the S&P BSE Mid-Cap index added 0.44% while the S&P BSE Small-Cap index rose 0.48%.

The market breadth was almost even. On the BSE, 1,781 shares rose and 1,706 shares fell. A total of 170 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 2.86% to 11.51. The Nifty 28 September 2023 futures were trading at 19,657.25, at a discount of 5.55 points as compared with the spot at 19,662.80.

The Nifty option chain for the 28 September 2023 expiry showed maximum Call OI of 157.9 lakh contracts at the 19,800 strike price. Maximum Put OI of 173.5 lakh contracts were seen at 19,600 strike price.

Buzzing Index:

The Nifty Pharma index rose 1.07% to 15,142.25. The index had declined 3.86% in the past six sessions.

Granules India (up 3.08%), Aurobindo Pharma (up 1.95%), Natco Pharma (up 1.86%), Lupin (up 1.53%) and Gland Pharma (up 1.52%) were the top gainers.

Among the other gainers were Laurus Labs (up 1.35%), Cipla (up 1.19%), Biocon (up 1.07%) and Zydus Lifesciences (up 1.06%).

Stocks in Spotlight:

Vedanta tumbled 5.56%. Moody's Investors Service downgraded parent Vedanta Resources' senior unsecured bonds, citing a high risk of debt restructuring in the coming months. The scrip had slumped 6.27% to hit the day's low at Rs 210, which is also a 52-week low for the counter.

HLE Glascoat jumped 6.14%. DSP Micro Cap Fund bought 3.52% stake via bulk deal on Tuesday, 26 September 2023.

Glenmark Pharmaceuticals rose 1.28%. The company said that its subsidiary Glenmark Specialty S.A. and Cosmo Pharmaceuticals N.V. has signed a distribution and license agreements for Winlevi (clascoterone cream 1%) in Europe and South Africa.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise